Cargando…

Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

Primary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we co...

Descripción completa

Detalles Bibliográficos
Autores principales: Teruel, María, Barturen, Guillermo, Martínez-Bueno, Manuel, Castellini-Pérez, Olivia, Barroso-Gil, Miguel, Povedano, Elena, Kerick, Martin, Català-Moll, Francesc, Makowska, Zuzanna, Buttgereit, Anne, Pers, Jacques-Olivier, Marañón, Concepción, Ballestar, Esteban, Martin, Javier, Carnero-Montoro, Elena, Alarcón-Riquelme, Marta E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640069/
https://www.ncbi.nlm.nih.gov/pubmed/34857786
http://dx.doi.org/10.1038/s41598-021-01324-0
_version_ 1784609259571380224
author Teruel, María
Barturen, Guillermo
Martínez-Bueno, Manuel
Castellini-Pérez, Olivia
Barroso-Gil, Miguel
Povedano, Elena
Kerick, Martin
Català-Moll, Francesc
Makowska, Zuzanna
Buttgereit, Anne
Pers, Jacques-Olivier
Marañón, Concepción
Ballestar, Esteban
Martin, Javier
Carnero-Montoro, Elena
Alarcón-Riquelme, Marta E.
author_facet Teruel, María
Barturen, Guillermo
Martínez-Bueno, Manuel
Castellini-Pérez, Olivia
Barroso-Gil, Miguel
Povedano, Elena
Kerick, Martin
Català-Moll, Francesc
Makowska, Zuzanna
Buttgereit, Anne
Pers, Jacques-Olivier
Marañón, Concepción
Ballestar, Esteban
Martin, Javier
Carnero-Montoro, Elena
Alarcón-Riquelme, Marta E.
author_sort Teruel, María
collection PubMed
description Primary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population.
format Online
Article
Text
id pubmed-8640069
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86400692021-12-06 Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature Teruel, María Barturen, Guillermo Martínez-Bueno, Manuel Castellini-Pérez, Olivia Barroso-Gil, Miguel Povedano, Elena Kerick, Martin Català-Moll, Francesc Makowska, Zuzanna Buttgereit, Anne Pers, Jacques-Olivier Marañón, Concepción Ballestar, Esteban Martin, Javier Carnero-Montoro, Elena Alarcón-Riquelme, Marta E. Sci Rep Article Primary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population. Nature Publishing Group UK 2021-12-02 /pmc/articles/PMC8640069/ /pubmed/34857786 http://dx.doi.org/10.1038/s41598-021-01324-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Teruel, María
Barturen, Guillermo
Martínez-Bueno, Manuel
Castellini-Pérez, Olivia
Barroso-Gil, Miguel
Povedano, Elena
Kerick, Martin
Català-Moll, Francesc
Makowska, Zuzanna
Buttgereit, Anne
Pers, Jacques-Olivier
Marañón, Concepción
Ballestar, Esteban
Martin, Javier
Carnero-Montoro, Elena
Alarcón-Riquelme, Marta E.
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_full Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_fullStr Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_full_unstemmed Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_short Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_sort integrative epigenomics in sjögren´s syndrome reveals novel pathways and a strong interaction between the hla, autoantibodies and the interferon signature
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640069/
https://www.ncbi.nlm.nih.gov/pubmed/34857786
http://dx.doi.org/10.1038/s41598-021-01324-0
work_keys_str_mv AT teruelmaria integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT barturenguillermo integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT martinezbuenomanuel integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT castelliniperezolivia integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT barrosogilmiguel integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT povedanoelena integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT kerickmartin integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT catalamollfrancesc integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT makowskazuzanna integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT buttgereitanne integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT persjacquesolivier integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT maranonconcepcion integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT ballestaresteban integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT martinjavier integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT carneromontoroelena integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT alarconriquelmemartae integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature